Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells
- 31 March 1998
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (7) , 3615-3620
- https://doi.org/10.1073/pnas.95.7.3615
Abstract
A kininogen binding protein(s), a putative receptor, was identified on endothelial cells. A 54-kDa protein was isolated by a biotin–high molecular mass kininogen (HK) affinity column that, on aminoterminal sequencing of tryptic digests, was identified as cytokeratin 1. Multiple antibodies directed to cytokeratin 1 reacted with a 54-kDa band on immunoblot of lysates of endothelial cells. On laser scanning confocal microscopy, cytokeratin 1 antigen was found on the surface of endothelial cells. Cytokeratin 1 antigen also was detected on endothelial cell membranes by flow cytometry. Moreover, an antipeptide antibody to a sequence unique to cytokeratin 1 also specifically bound to nonpermeabilized endothelial cells. Biotin–HK specifically bound to cytokeratin only in the presence of Zn2+, and cytokeratin blocked biotin–HK binding to endothelial cells. Further, HK and low molecular mass kininogen, but not factor XII, blocked biotin–HK binding to cytokeratin, and peptides of each cell binding region of HK on domains 3,4, and 5 blocked biotin–HK binding to cytokeratin. gC1qR and soluble urokinase-like plasminogen activator receptor also inhibited biotin–HK binding to cytokeratin. These investigations identify a new function for cytokeratin 1 as a kininogen binding protein. Cytokeratins, members of the family of intermediate filament proteins, may represent a new class of receptors.Keywords
This publication has 38 references indexed in Scilit:
- Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.Journal of Clinical Investigation, 1997
- Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cellsFEBS Letters, 1996
- Cell-surface Cytokeratin 8 Is the Major Plasminogen Receptor on Breast Cancer Cells and Is Required for the Accelerated Activation of Cell-associated Plasminogen by Tissue-type Plasminogen ActivatorJournal of Biological Chemistry, 1996
- Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.Journal of Clinical Investigation, 1993
- Bradykinin induces superoxide anion release from human endothelial cellsJournal of Cellular Physiology, 1990
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- High molecular weight kininogen binds to unstimulated platelets.Journal of Clinical Investigation, 1986
- Receptors for high molecular weight kininogen on stimulated washed human plateletsBiochemistry, 1984
- Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocelluloseGene Analysis Techniques, 1984
- Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells studies with lower homologs and calcium antagonistsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983